JP2025515314A5 - - Google Patents

Info

Publication number
JP2025515314A5
JP2025515314A5 JP2024563042A JP2024563042A JP2025515314A5 JP 2025515314 A5 JP2025515314 A5 JP 2025515314A5 JP 2024563042 A JP2024563042 A JP 2024563042A JP 2024563042 A JP2024563042 A JP 2024563042A JP 2025515314 A5 JP2025515314 A5 JP 2025515314A5
Authority
JP
Japan
Prior art keywords
composition according
composition
compound
mosm
phosphate buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024563042A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515314A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/019807 external-priority patent/WO2023211932A1/en
Publication of JP2025515314A publication Critical patent/JP2025515314A/ja
Publication of JP2025515314A5 publication Critical patent/JP2025515314A5/ja
Pending legal-status Critical Current

Links

JP2024563042A 2022-04-28 2023-04-25 緩衝剤を含有する組成物及びその使用方法 Pending JP2025515314A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263335822P 2022-04-28 2022-04-28
US63/335,822 2022-04-28
PCT/US2023/019807 WO2023211932A1 (en) 2022-04-28 2023-04-25 Buffering agent-containing compositions and methods of using same

Publications (2)

Publication Number Publication Date
JP2025515314A JP2025515314A (ja) 2025-05-14
JP2025515314A5 true JP2025515314A5 (enExample) 2026-05-11

Family

ID=86469370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024563042A Pending JP2025515314A (ja) 2022-04-28 2023-04-25 緩衝剤を含有する組成物及びその使用方法

Country Status (7)

Country Link
US (1) US20250281512A1 (enExample)
EP (1) EP4514319A1 (enExample)
JP (1) JP2025515314A (enExample)
CN (1) CN119136783A (enExample)
AU (1) AU2023260344A1 (enExample)
CA (1) CA3250927A1 (enExample)
WO (1) WO2023211932A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250339449A1 (en) * 2024-05-02 2025-11-06 Know Bio, Llc Inhalation formulations containing nitric oxide releasing compounds and methods of using same
CN119523952B (zh) * 2024-10-17 2026-03-10 河北医科大学 一种多黏菌素吸入液体制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
US20120076859A1 (en) * 2010-09-23 2012-03-29 Activaero Gmbh Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases
CA3280124A1 (en) * 2013-07-31 2025-10-31 Avalyn Pharma Inc. Aerosol imatinib compounds and uses thereof
EP4548975A3 (en) * 2015-09-09 2025-07-23 Beyond Air Ltd Nitric oxide inhalation therapy for infants with bronchiolitis
US12390479B2 (en) * 2020-02-07 2025-08-19 Know Bio, Llc Nitric oxide-releasing antibacterial compounds, formulations, and methods pertaining thereto
WO2022051606A1 (en) * 2020-09-04 2022-03-10 Know Bio, Llc Nitric oxide donors, compositions, and methods of use

Similar Documents

Publication Publication Date Title
JP2023538260A5 (enExample)
US5707970A (en) Arginine silicate complex and use thereof
JP2019528320A5 (enExample)
JP2013530179A5 (enExample)
JPH1129497A5 (enExample)
JP2001525359A5 (enExample)
JP2010503731A5 (enExample)
US6822112B1 (en) Prostaglandin derivatives
FI3710036T3 (fi) Stabiileja askorbiinihappokoostumuksia ja menetelmiä niiden käyttämiseksi
JP2021530559A5 (enExample)
JP2022530637A5 (enExample)
JP2024544538A5 (enExample)
JP2021525787A5 (enExample)
JP2004509854A5 (enExample)
JP2021519764A5 (enExample)
JP2022527401A5 (enExample)
JP2024009811A5 (enExample)
JP2024517003A5 (enExample)
CA2530774A1 (en) Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
RU2007107935A (ru) Полисульфатированные гликозиды и их соли
JP2025507180A (ja) 肺線維症治療のための薬物の調製におけるヒポキサンチン化合物の使用
JP2002505328A (ja) 抗潰瘍医薬の硝酸塩
CA2534120A1 (en) Medicaments for inhalation comprising anticholinergics and a betamimetic
JP2020513041A5 (enExample)
TWI500421B (zh) Pharmaceutical composition